JNCCN 360 - Non–Small Cell Lung Cancer - Ongoing CE Activities

Editor:

Gregory J. Riely, MD, PhD

Advertisement

Advertisement

Ongoing CE Activities

Applying the Latest Evidence in the Management of Early-Stage Non-Small Cell Lung Cancer

Implications of Recent Data Sets for the Current and Future Management of Lung Cancer

Improving Lung Cancer Care Through Understanding the Patient Experience

Key Presentations on Lung Cancer from Recent Major Conferences

Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Lung Cancer from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

Striving for Consensus: Current and Future Management of Metastatic Non-Small Cell Lung Cancer in Patients Who Experience Disease Progression on Immune Checkpoint Inhibitor Therapy

Targeted Therapy for Fusions

The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with Actionable Targets Beyond EGFR

Unlocking the Potential of Neoadjuvant and Adjuvant Immunotherapy in Resectable NSCLC: the Role of Checkpoint Inhibitors

Sections

NCCN Resources

Copyright © 2025 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.